Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1988 Aug;58(2):182–185. doi: 10.1038/bjc.1988.188

B-lymphocytes from melanoma patients and normal individuals react with melanoma cells but also with irrelevant antigens.

B E Damato 1, A M Campbell 1, B J McGuire 1, W R Lee 1, W S Foulds 1
PMCID: PMC2246765  PMID: 3262365

Abstract

Peripheral B-lymphocytes of 13 patients with uveal melanoma and of 5 healthy individuals were transformed with Epstein-Barr virus (EBV). The reactivity of these transformed cells with autologous or allogeneic melanoma cells and lymphocytes was measured by the enzyme-linked immunosorbent assay (ELISA). Antigens which are neither self nor common environmental antigens (i.e., plant protoplasts, schistosome antigen and keyhole limpet haemocyanin) were used for controls. Lymphocyte reactivity with all types of antigen was apparent both in patients with uveal melanoma and in normal controls. The response detected by the techniques available is likely to reflect antibody multispecificity leading to mis-identification of irrelevant antigens.

Full text

PDF
182

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bird A. G., McLachlan S. M., Britton S. Cyclosporin A promotes spontaneous outgrowth in vitro of Epstein-Barr virus-induced B-cell lines. Nature. 1981 Jan 22;289(5795):300–301. doi: 10.1038/289300a0. [DOI] [PubMed] [Google Scholar]
  2. Campbell A. M., McCormack M. A., Ross C. A., Leake R. E. Immunological analysis of the specificity of the autologous humoral response in breast cancer patients. Br J Cancer. 1986 Jan;53(1):7–11. doi: 10.1038/bjc.1986.2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Campbell A. M., Whitford P., Leake R. E. Human monoclonal antibodies and monoclonal antibody multispecificity. Br J Cancer. 1987 Dec;56(6):709–713. doi: 10.1038/bjc.1987.275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chan M. A., Stein L. D., Dosch H. M., Sigal N. H. Heterogeneity of EBV-transformable human B lymphocyte populations. J Immunol. 1986 Jan;136(1):106–112. [PubMed] [Google Scholar]
  5. Cote R. J., Morrissey D. M., Houghton A. N., Beattie E. J., Jr, Oettgen H. F., Old L. J. Generation of human monoclonal antibodies reactive with cellular antigens. Proc Natl Acad Sci U S A. 1983 Apr;80(7):2026–2030. doi: 10.1073/pnas.80.7.2026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cote R. J., Morrissey D. M., Houghton A. N., Thomson T. M., Daly M. E., Oettgen H. F., Old L. J. Specificity analysis of human monoclonal antibodies reactive with cell surface and intracellular antigens. Proc Natl Acad Sci U S A. 1986 May;83(9):2959–2963. doi: 10.1073/pnas.83.9.2959. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Damato B. E., Campbell A. M., McGuire B. J., Lee W. R., Foulds W. S. Monoclonal antibodies to human primary uveal melanomas demonstrate tumor heterogeneity. Invest Ophthalmol Vis Sci. 1986 Sep;27(9):1362–1367. [PubMed] [Google Scholar]
  8. Effros R. B., Zeller E., Dillard L., Walford R. L. Detection of antibodies to cell surface antigens by a simplified cellular ELISA (CELISA). Tissue Antigens. 1985 Apr;25(4):204–211. doi: 10.1111/j.1399-0039.1985.tb00438.x. [DOI] [PubMed] [Google Scholar]
  9. Foulds W. S. The local excision of choroidal melanomata. Trans Ophthalmol Soc U K. 1973;93(0):343–346. [PubMed] [Google Scholar]
  10. Heppner G. H. Tumor heterogeneity. Cancer Res. 1984 Jun;44(6):2259–2265. [PubMed] [Google Scholar]
  11. Houghton A. N., Brooks H., Cote R. J., Taormina M. C., Oettgen H. F., Old L. J. Detection of cell surface and intracellular antigens by human monoclonal antibodies. Hybrid cell lines derived from lymphocytes of patients with malignant melanoma. J Exp Med. 1983 Jul 1;158(1):53–65. doi: 10.1084/jem.158.1.53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Houghton A. N., Taormina M. C., Ikeda H., Watanabe T., Oettgen H. F., Old L. J. Serological survey of normal humans for natural antibody to cell surface antigens of melanoma. Proc Natl Acad Sci U S A. 1980 Jul;77(7):4260–4264. doi: 10.1073/pnas.77.7.4260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Miller F. R. Intratumor immunologic heterogeneity. Cancer Metastasis Rev. 1982;1(4):319–334. doi: 10.1007/BF00124215. [DOI] [PubMed] [Google Scholar]
  14. Miller G., Lipman M. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proc Natl Acad Sci U S A. 1973 Jan;70(1):190–194. doi: 10.1073/pnas.70.1.190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Natali P. G., Cavaliere R., Bigotti A., Nicotra M. R., Russo C., Ng A. K., Giacomini P., Ferrone S. Antigenic heterogeneity of surgically removed primary and autologous metastatic human melanoma lesions. J Immunol. 1983 Mar;130(3):1462–1466. [PubMed] [Google Scholar]
  16. Shevach E. M. The effects of cyclosporin A on the immune system. Annu Rev Immunol. 1985;3:397–423. doi: 10.1146/annurev.iy.03.040185.002145. [DOI] [PubMed] [Google Scholar]
  17. Steel C. M., Philipson J., Arthur E., Gardiner S. E., Newton M. S., McIntosh R. V. Possibility of EB virus preferentially transforming a subpopulation of human B lymphocytes. Nature. 1977 Dec 22;270(5639):729–731. doi: 10.1038/270729a0. [DOI] [PubMed] [Google Scholar]
  18. Steinitz M., Koskimies S., Klein G., Mäkelä O. Establishment of specific antibody producing human lines by antigen preselection and Epstein-Barr virus (EBV)-transformation. J Clin Lab Immunol. 1979 Apr;2(1):1–7. [PubMed] [Google Scholar]
  19. Winger L., Winger C., Shastry P., Russell A., Longenecker M. Efficient generation in vitro, from human peripheral blood cells, of monoclonal Epstein-Barr virus transformants producing specific antibody to a variety of antigens without prior deliberate immunization. Proc Natl Acad Sci U S A. 1983 Jul;80(14):4484–4488. doi: 10.1073/pnas.80.14.4484. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES